Dr. Gang Song 宋刚
Chief Physician, Associate Professor
Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Robotic and laparoscopic surgery for prostate, kidney, and bladder cancer. MRI-ultrasound fusion prostate biopsy. Comprehensive treatment for advanced prostate cancer.
Dr. Song holds a clinical doctorate in urology from Peking University. Previously at Peking University First Hospital, serving as ward group leader (2016–2019). Joined the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences in 2022. Currently serves as Deputy Director of Urology at the Langfang campus and master’s supervisor at Peking Union Medical College.
Professional roles
- Member, Chinese Medical Association
- Secretary, Youth Committee of Urology Branch, Chinese Medical Doctor Association
- Member, Laparoscopic Endoscopic Surgery Branch, China International Exchange and Promotion Association for Medical and Health Care
- Editorial Board Member, Journal of Urology (Electronic Edition)
Name order: in Chinese the family name comes first (Song Gang). Papers usually list the name as Gang Song or Song G.
Selected publications
5 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biomedicines, 2026 (senior author): High-Resolution Spatial Transcriptomics Reveals Pathological Microregion-Specific Luminal Subset Plasticity and Core Signaling Networks Underlying Prostate Cancer Malignancy. PubMed 42652093
- Clin Genitourin Cancer, 2025 (senior author): Impact of TP53 Alterations on Clinical Outcomes in Penile Squamous Cell Carcinoma. PubMed 40240224
- Investig Clin Urol, 2023 (senior author): A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer. PubMed 37417561
- Abdom Radiol (NY), 2023 (senior author): Novel sampling scheme with reduced cores in men with multiparametric MRI-visible lesions undergoing prostate biopsy. PubMed 37036488
- Abdom Radiol (NY), 2023 (senior author): MRI-based analysis of different clinically significant prostate cancer detection rate of prostate imaging reporting and data system score 4 in the peripheral zone. PubMed 36305943
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion